about
Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryThe nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-SeqSensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissuePaired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.Factors Associated with the Size of HIV DNA Reservoir.Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4(+) T lymphocytes and reactivation of the HIV-1 reservoir.Current views on interferon therapy for HIV.Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?Mechanisms of HIV persistence in HIV reservoirs.Fight fire with fire: Gene therapy strategies to cure HIV.Can sugarcoated fingerprints be used to identify lurking viruses?Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA.A higher CD4/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study.Myeloid Cell Interaction with HIV: A Complex Relationship.Tools for Visualizing HIV in Cure Research.HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency.Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study.Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathwayCD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV ControlReversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization
P2860
Q33742139-FCBF2B39-AC21-498E-A8E3-F5935ED98910Q36243217-80649C1A-5FD5-4804-9F20-7280BF5BB437Q36348536-CA9FFFC3-8570-4646-8086-9ECAAFB5931AQ37493334-C2052F76-0DEE-4C89-9D6C-FC1B82C468B9Q37615584-0A52E601-9D9B-4E07-9030-C4BE78DD3CA1Q38660421-3F38ABBD-74A0-43FF-9861-2E9D703CB9F0Q38802980-96A6785F-0791-4D8D-B8A2-2240187F6CD9Q38860634-8E65D71C-0E02-4079-8C0D-EDDED3252D61Q38963668-3F4B2CD7-F182-494F-ADFA-A87C423B83EAQ39106572-C630EF58-ECDB-4659-BE39-59CC22D5509BQ39425614-7B65867D-2C6D-4216-8BE3-BB4BE81C48C6Q39686508-A1E39527-46E8-48F4-80C3-76D00EAFE418Q41932909-8F69C393-40E9-426C-86F7-B8F7EDF5FCE8Q47096232-4B5E6229-970D-4AF0-B608-B401A6D07CD2Q47141408-F10246BE-C1AF-4DFF-BA79-DD68E37FFC66Q47548551-3EBD2E15-EE68-4B64-90FA-A26D2D79E7BEQ47563715-DD6AE927-9631-4599-B3D7-7E21E3482D99Q50022535-B16A86F7-C53C-4E4A-83E0-27FD2C1CA6E1Q55438209-602A29D1-7A16-4E54-8D16-1E49FD6C2E5BQ57050517-316E139F-1477-4172-93E2-2E712E5E49DCQ57811386-7BCC93BD-C42A-460B-9732-7164FCEA8AC9Q58700378-54C6A24A-C78F-4E53-B727-39DBECE34105
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-1 Reservoirs During Suppressive Therapy.
@en
HIV-1 Reservoirs During Suppressive Therapy.
@nl
type
label
HIV-1 Reservoirs During Suppressive Therapy.
@en
HIV-1 Reservoirs During Suppressive Therapy.
@nl
prefLabel
HIV-1 Reservoirs During Suppressive Therapy.
@en
HIV-1 Reservoirs During Suppressive Therapy.
@nl
P2093
P2860
P1476
HIV-1 Reservoirs During Suppressive Therapy.
@en
P2093
Anni Winckelmann
Kirston Barton
Sarah Palmer
P2860
P304
P356
10.1016/J.TIM.2016.01.006
P577
2016-02-11T00:00:00Z